Polymorphisms in the SAA1 gene are associated with ankle-to-brachial index in Han Chinese healthy subjects

Blood Pressure

Volumn 20, Issue 4, 2011, Pages 232-238

  Xie, Xiang ^a,b   Ma, Yi Tong ^a,b   Yang, Yi Ning ^a,b   Fu, Zhen Yan ^a,b   Li, Xiao Mei ^a,b   Zheng, Ying Ying ^a,b   Huang, Ding ^a   Ma, Xiang ^a,b   Chen, Bang Dang ^b   Liu, Fen ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Xinjiang Key Laboratory of Cardiovascular Disease Research   (China)

Author keywords

Ankle to brachial index; Genetics; Serum amyloid A protein

Indexed keywords

HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID A;

ADULT; ALCOHOL CONSUMPTION; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CIGARETTE SMOKING; DNA POLYMORPHISM; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HEALTH SURVEY; HUMAN; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION RESTRICTION FRAGMENT LENGTH POLYMORPHISM; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASES; CHINA; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SERUM AMYLOID A PROTEIN;

EID: 79960772854     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2011.566244     Document Type: Article

References (29)

1. Doobay AV, Anand SS. Sensitivity and specifi city of the ankle brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol. 2005; 25:1463-1469. (Pubitemid 40923369)
2. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:E16-E22.
3. Smith SC, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Executive summary. American Heart Association. Circulation. 2000;101:111-116. (Pubitemid 30039085)
4. Doobay AV, Anand SS. The sensitivity and specifi city of the ankle - brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol. 2005, 25:1-7.
5. Newman AB, Tyrrell KS, Kuller LH. Mortality over four years in SHEP participants with a low ankle - arm index. J Am Geriatr Soc. 1997;45:1472-1478. (Pubitemid 27523123)
6. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle - arm index as a predictor of CVD and mortality in the Cardiovascular Health Study: The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19:538-545. (Pubitemid 29135153)
7. Li J, Li JJ, Li Qian, Li Zhen, Qian HY. A rational connection of infl ammation with peripheral arterial disease. Med hypoth 2007;69:1190-1195. (Pubitemid 47633047)
8. Volpato S, Vigna GB, McDermott MM, Cavalieri M, Maraldi C, Lauretani F, et al. Lipoprotein (a), infl ammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study).Am JCardiol. 2010;105:1825 - 1830.
9. Ford ES, Greenwald J H, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010;24:1509-1517.
10. Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H .The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 1993;32: 729-733. (Pubitemid 23249181)
11. Scalapino KJ, Davis JC Jr. The treatment of ankylosing spondylitis. Clin Exp Med 2003;2:159-165. (Pubitemid 36313180)
12. Schillinger M, Exner M, Mlekusch W, Ssbeti S, Amighi J, Nikowitsch R, et al. Infl ammation and Carotid Artery - Risk for Atherosclerosis study (ICATAS).Circulation. 2005;111: 2203-2209.
13. Fyfe AI, Rothenberg LS, de Beer FC, Cantor RM, Rotter JI, Lusis AJ. Association between serum amyloid A proteins and coronary artery disease: Evidence from two distinct arteriosclerotic processes. Circulation. 1997;96:2914-2919. (Pubitemid 27500090)
14. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, et al. National Heart, Lung, and Blood Institute. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-sponsored Women ' s Ischemia Syndrom Evaluation (WISE).Circulation. 2004;109: 726-732. (Pubitemid 38222891)
15. Carty CL, Heagerty P, Heckbert SR, Enquobahrie DA, Jarvik GP, Davis S, et al. Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1 a and TNF gene in the cardiovascular health study. J Ather Throm. 2009;16:419-430.
16. Xie X, Ma Y-T, Yang Y-N, Fu Z-Y, Li X-M, et al. Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy Han Chinese subjects: The Cardiovascular Risk Survey. PLoS ONE 2010;5 (11):e13997. doi:10.1371/ journal.pone.0013997
17. Xie X, Ma Y-T, Yang Y-N, Fu Z-Y, Li X-M, et al. Alcohol Consumption and ankle-to-brachial index: Results from the Cardiovascular Risk Survey. PLoS ONE 2010;5 (12):e15181. doi: 10.1371/journal.pone.0015181.
18. Patel S, Flyvbjerg A, Kozàk ovàM, Frystyk J, Ibrahim IM, Petrie JR, et al.; RISC Investigators. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J. 2008;29:386-393. (Pubitemid 351197748)
19. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, Li XM, et al. Haplotype analysis of the CYP8A1 gene associated with myocardial infarction. Clin Appl Thromb-Hem. 2009;15:574-580.
20. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, Li XM, et al. Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction. Clin Chem Lab Med. 2009;47:347-352.
21. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice. Eur J Clin Invest.1996;26:427-435. (Pubitemid 26226404)
22. Benditt EP, Eriksen N, Hermodson MA, Ericsson LHThe major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences. FEBS Lett. 1971;19:169-173.
23. Levin M, Franklin EC, Frangione B, Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fi brils. J Clin Invest. 1972;51:2773-2776.
24. Benditt EP, Hoffman JS, Eriksen N, Parmelee DC, Walsh KA. SAA, an apoprotein of HDL: Its structure and function. Ann N Y Acad Sci. 1982;389:183-189. (Pubitemid 12013188)
25. Clifton PM, Mackinnon AM, Barter PJ. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res. 1985;26:1389-1398. (Pubitemid 16189736)
26. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, et al. Serum amyloid A-containing human high density lipoprotein 3: Density, size, and apolipoprotein composition. J Biol Chem. 1986;261: 9644-9651. (Pubitemid 17214087)
27. Graversen JH, Castro G, Kandussi A, Nielsen H, Christensen EI, et al. A pivital role of the human kidney in catabolism of HDL. Protein components apolipopro tein A-I and A-IV but not of A-II. Lipids. 2008;43:467-470.
28. Lowell CA, Stearman RS, Morrow JF. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem. 1986;261:8453-8461. (Pubitemid 17202726)
29. Navarro MA, Carpintero R, Acin S, Arbones-Mainar JM, Calleja L, et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental infl ammation. Cytokine. 2005;31:52-63. (Pubitemid 40828359)